Maxalt (Rizatriptan Benzoate)

Rizatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors in the brain. This action causes constriction of dilated cranial blood vessels and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade and reducing pain.

The dose of Maxalt is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for rizatriptan in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Maxalt.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Maxalt belongs to the triptan class, which is specifically designed for acute migraine relief. Compared with non‑specific analgesics, triptans target serotonin receptors for faster and more effective headache resolution. Alternative triptans (e.g., sumatriptan) have similar mechanisms but may differ in onset speed, duration, and side‑effect profile.

Store Maxalt tablets at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the medication out of reach of children and do not use it after the expiration date printed on the package.

Maxalt is taken orally as a tablet. The patient should swallow the tablet whole with a glass of water, preferably as soon as migraine symptoms begin. If needed, a second dose may be taken after a minimum interval of two hours, as directed by the prescriber.

Serious risks include serotonin syndrome when combined with other serotonergic drugs, coronary vasospasm leading to chest pain or heart attack, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience chest discomfort, rapid heartbeat, or signs of an allergic reaction.

Maxalt should be avoided in patients with uncontrolled hypertension, known coronary artery disease, a history of myocardial infarction, severe liver impairment, or in those who have had a previous hypersensitivity reaction to rizatriptan or any component of the tablet.